Chiu H H, Crowe D T, Renz M E, Presta L G, Jones S, Weissman I L, Fong S
Department of Immunology, Genetech, Inc., South San Francisco, CA 94080, USA.
J Immunol. 1995 Dec 1;155(11):5257-67.
The integrin receptors alpha 4 beta 1 and alpha 4 beta 7 both bind to vascular cell adhesion molecule-1 (VCAM-1). Here, we report that the amino acid residue requirements for murine VCAM-1 adhesion to murine alpha 4 beta 1 (WEHI 231) and alpha 4 beta 7 (38C13/beta 7-transfectant) positive cells are strikingly similar but nonidentical under multiple adhesion activity states. By site-directed mutagenesis of domain 1 of VCAM-1, the amino acid residues on the loop between beta strands C and D (R36, Q38, I39, D40, P42) and on the adjacent antiparallel beta strand F (L70 and T72) were required for basal level adhesion to both alpha 4 beta 1-positive and alpha 4 beta 7-positive cells. Mutation at two other sites, N44 (loop between beta strands C and D) and E66 (loop between beta strands E and F), specifically reduced alpha 4 beta 7-positive cell adhesion, but not alpha 4 beta 1-positive cell adhesion. Mutation H85A augmented alpha 4 beta 7 binding but not alpha 4 beta 1 binding. These apparent differences relate to the higher intrinsic activity state of alpha 4 beta 1 on WEHI 231 than on alpha 4 beta 7 (38C13/beta 7-transfectant). In contrast, under higher adhesion activity states induced by either MnCl2 or truncation of the beta 7 cytoplasmic tail, mutation of either amino acid residue D40 or L70 completely blocked cell adhesion without evidence of structural perturbation of VCAM-1. These results suggested that the two structurally discontinuous amino acid residues, the negatively charged D40 and the hydrophobic L70 adjacently located on domain 1 of VCAM-1, are essential for interaction under multiple activity states with both alpha 4 beta 1 and alpha 4 beta 7 integrin receptors.
整合素受体α4β1和α4β7均与血管细胞黏附分子-1(VCAM-1)结合。在此,我们报告,在多种黏附活性状态下,小鼠VCAM-1与小鼠α4β1(WEHI 231)和α4β7(38C13/β7转染细胞)阳性细胞黏附的氨基酸残基要求惊人地相似但并不完全相同。通过对VCAM-1结构域1进行定点诱变,发现β链C和D之间的环上(R36、Q38、I39、D40、P42)以及相邻的反平行β链F上(L70和T72)的氨基酸残基是与α4β1阳性和α4β7阳性细胞进行基础水平黏附所必需的。另外两个位点N44(β链C和D之间的环)和E66(β链E和F之间的环)的突变特异性地降低了α4β7阳性细胞的黏附,但不影响α4β1阳性细胞的黏附。H85A突变增强了α4β7的结合,但不增强α4β1的结合。这些明显的差异与α4β1在WEHI 231上比在α4β7(38C13/β7转染细胞)上具有更高的内在活性状态有关。相反,在由MnCl2或β7细胞质尾巴截断诱导的更高黏附活性状态下,氨基酸残基D40或L70的突变完全阻断了细胞黏附,且没有证据表明VCAM-1的结构受到扰动。这些结果表明,在VCAM-1结构域1上相邻定位的两个结构上不连续的氨基酸残基,即带负电荷的D40和疏水性的L70,对于在多种活性状态下与α4β1和α4β7整合素受体相互作用至关重要。